We help our clients achieve positive pharmaceutical regulatory outcomes by using a modern, scientific approach as the driver of success. We support our clients from pre- through post-approval for both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) and similar Organization in geographical regions. MENA-Middle East and North Africa. APAC – Asia Pacific, EMEA – Europe, Middle East and Africa, LAD – Latin America Division, NA – North America, WANA (West Asia and North Africa)

B.K. Bright Innovative Research continues to build upon our strong team of regulatory science in various countries, that further globalize and deepen our service capabilities. Our integrated team of pharmaceutical regulation specialists has grown through uniting leading local regulatory affairs companies